These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28326948)

  • 1. Rare presentation of intrathecal morphine withdrawal psychosis.
    Aiyer R; Jain V; Bhatia A; Mekinulov B; Gungor S
    Pain Manag; 2017 May; 7(3):171-173. PubMed ID: 28326948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withdrawal symptoms in a patient receiving intrathecal morphine via an infusion pump.
    Hu K; Connelly NR; Vieira P
    J Clin Anesth; 2002 Dec; 14(8):595-7. PubMed ID: 12565119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of uncommon withdrawal symptoms after a short period of spinal morphine administration.
    Devulder J; Bohyn P; Castille F; De Laat M; Rolly G
    Pain; 1996 Mar; 64(3):589-591. PubMed ID: 8783325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ziconotide: A rapid detoxification protocol for the conversion from intrathecal morphine--the Raffaeli Detoxification Model.
    Raffaeli W; Righetti D; Sarti D; Balestri M; Ferioli I; Monterubbianesi MC; Caminiti A
    J Opioid Manag; 2011; 7(1):21-6. PubMed ID: 21434581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis.
    Shaladi A; Saltari MR; Piva B; Crestani F; Tartari S; Pinato P; Micheletto G; Dall'Ara R
    Clin J Pain; 2007; 23(6):511-7. PubMed ID: 17575491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A differential diagnosis of hyperalgesia, toxicity, and withdrawal from intrathecal morphine infusion.
    Singla A; Stojanovic MP; Chen L; Mao J
    Anesth Analg; 2007 Dec; 105(6):1816-9, table of contents. PubMed ID: 18042887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal Clonidine Pump Failure Causing Acute Withdrawal Syndrome With 'Stress-Induced' Cardiomyopathy.
    Lee HM; Ruggoo V; Graudins A
    J Med Toxicol; 2016 Mar; 12(1):134-8. PubMed ID: 26370679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
    Setnik B; Roland CL; Goli V; Sommerville K; Webster L
    J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Opioid therapy for chronic noncancer pain: retrospective analysis of patients hospitalized for withdrawal].
    Faure D; Giniès P; Eiden C; Portet L; Peyrière H
    Therapie; 2013; 68(6):385-92. PubMed ID: 24356190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ondansetron Does Not Reduce Withdrawal in Patients With Physical Dependence on Chronic Opioid Therapy.
    Chu LF; Sun J; Clemenson A; Erlendson MJ; Rico T; Cornell E; Obasi H; Sayyid ZN; Encisco EM; Yu J; Gamble JG; Carroll I; Clark JD
    J Addict Med; 2017; 11(5):342-349. PubMed ID: 28514235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain.
    Webster LR; Fakata KL; Charapata S; Fisher R; MineHart M
    Pain Med; 2008 Apr; 9(3):282-90. PubMed ID: 18366508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adolescent female with withdrawal psychosis following abrupt termination of ziprasidone.
    Jacob MK; Ash P; Craighead WE
    Eur Child Adolesc Psychiatry; 2012 Mar; 21(3):165-8. PubMed ID: 22249643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain.
    Wallace MS; Kosek PS; Staats P; Fisher R; Schultz DM; Leong M
    Pain Med; 2008 Apr; 9(3):271-81. PubMed ID: 18366507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
    Dunbar SA; Karamian I; Zhang J
    Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity of Withdrawal Symptoms During Opioid Taper in Patients with Chronic Pain-Individualized or Fixed Starting Dosage?
    Bienek N; Maier C; Kaisler M; Michel-Lauter B; Schwarzer A; Meyer-Frießem CH
    Pain Med; 2019 Dec; 20(12):2438-2449. PubMed ID: 30806672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-related side effects of long-term intrathecal morphine therapy.
    Ruan X
    Pain Physician; 2007 Mar; 10(2):357-66. PubMed ID: 17387357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship Between the Mechanisms of Action and Safety Profiles of Intrathecal Morphine and Ziconotide: A Review of the Literature.
    Webster LR
    Pain Med; 2015 Jul; 16(7):1265-77. PubMed ID: 25645109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transverse myelopathy as a complication following long-term intrathecal application of morphine in chronic back pain].
    Schimpf J; Krakow K; Vehreschild N; Pohlmann-Eden B
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Aug; 34(8):506-9. PubMed ID: 10494374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intentional intrathecal opioid detoxification in 3 patients: characterization of the intrathecal opioid withdrawal syndrome.
    Jackson TP; Lonergan DF; Todd RD; Martin PR
    Pain Pract; 2013 Apr; 13(4):297-309. PubMed ID: 22925591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent hiccup associated with intrathecal morphine infusion pump therapy.
    Ruan X; Couch JP; Shah R; Wang F; Liu HN
    Am J Phys Med Rehabil; 2007 Dec; 86(12):1019-22. PubMed ID: 18090443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.